Market Tracker

06/27 5:16pm ET

Biomarin Pharmaceutical Inc (NASDAQ:BMRN)

89.63
Delayed Data
As of 3:59pm ET
 -3.84 / -4.11%
Today’s Change
73.45
Today|||52-Week Range
102.49
+8.20%
Year-to-Date

Today’s Trading

Previous close93.47
Today’s open93.31
Day’s range89.50 - 94.17
Volume1,580,858
Average volume (3 months)1,193,210
Market cap$16.3B
Dividend yield--
Data as of 3:59pm ET, 06/27/2017

Growth & Valuation

Earnings growth (last year)-256.07%
Earnings growth (this year)+78.61%
Earnings growth (next 5 years)+127.00%
Revenue growth (last year)+27.18%
P/E ratioNM
Price/Sales12.40
Price/Book5.83

Competitors

 Today’s
change
Today’s
% change
MYLMylan NV-0.60-1.54%
PRGOPerrigo Company PLC-1.16-1.53%
JAZZJazz Pharmaceuticals...-3.94-2.48%
ALKSAlkermes Plc-1.18-2.02%
Data as of 4:02pm ET, 06/27/2017

Financials

Next reporting dateAugust 2, 2017
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$1.1B
Annual profit (last year)-$630.2M
Net profit margin-56.74%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Jean-Jacques Bienaimé
Chief Financial Officer &
Executive Vice President
Daniel K. Spiegelman
Corporate headquarters
San Rafael, California

Forecasts